Yumizen H500 full blood count analyzer demonstrates exceptional correlation with larger laboratory-based systems HORIBA UK Ltd, Medical announces the publication of two studies successfully evaluating ...

HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments. The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s ...

HORIBA Medical announces that it will be showcasing the very latest additions to its Yumizen G range of hemostasis analyzers and reagents at ISTH 2022 Congress - the premier event in the field of ...

HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation ...

The Malaria flag of HORIBA Medical delivers a Suspicion Malaria Infection screening performed on regular use on hematology analyzers. With this new flag, HORIBA Medical strives to contribute to ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

HORIBA India, a group company of HORIBA, Ltd., a Kyoto based Japanese leader in analytical equipment and measurement solutions for the three megatrend fields of energy & environment, bio & healthcare, ...

Horiba ( (HRIBF)) has released its Q3 earnings. Here is a breakdown of the information Horiba presented to its investors. HORIBA, Ltd. is a Japanese company specializing in the production of precision ...

Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in ...